CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale Principal Accounting Officer sold 1,985 shares at $22.64 ($44,940)
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Option exercise Director acquired 4,381 shares (option exercise)
- 4 Open-market sale EVP,General Counsel, Secretary sold 16,369 shares at $21.96 ($359,463)
- 4 Open-market sale CEO sold 51,563 shares at $21.96 ($1,132,323)
- 4 Planned sale Principal Accounting Officer sold 2,000 shares at $25.88 ($51,760)
- 144 Insider Sale of Securities
- 4 Planned sale EVP, Chief Financial Officer sold 10,000 shares at $29.00 ($289,970)
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale CEO sold 100,000 shares at $30.04 ($3,004,350)
- 8-K Event Material agreement · Results of operations
- 144 Insider Sale of Securities
- 4 Planned sale CEO sold 71,602 shares at an average $25.04 ($1,792,899)
- 144 Insider Sale of Securities
- 4 Planned sale Principal Accounting Officer sold 2,000 shares at $24.15 ($48,300)
- 144 Insider Sale of Securities
Page 11 of 70 · 1,382 filings